[1] |
Annane D, Ouanes-Besbes L, de Backer D, et al. A global perspective on vasoactive agents in shock[J]. Intensive Care Med, 2018, 44(6):833-846.
DOI
PMID
|
[2] |
Burgunder L, Heyrend C, Olson J, et al. Medication and fluid management of pediatric sepsis and septic shock[J]. Paediatr Drugs, 2022, 24(3):193-205.
|
[3] |
钟竹青, 秦宁, 高学琴, 等. 临床护士输注血管活性药物的现状调查[J]. 中华护理杂志, 2021, 56(8):1208-1215.
DOI
URL
|
|
Zhong ZQ, Qin N, Gao XQ, et al. Current status of infusion of vasoactive agents of nurses:a nationwide survey[J]. Chin J Nurs, 2021, 56(8):1208-1215.
|
[4] |
Hunter S, Considine J, Manias E. Nurse management of vasoactive medications in intensive care:a systematic review[J]. J Clin Nurs, 2020, 29(3/4):381-392.
|
[5] |
江莹, 黎万汇, 陈莹莹, 等. 经外周静脉输注血管活性药物风险管理范围的综述[J]. 中华护理杂志, 2021, 56(7):1105-1110.
DOI
URL
|
|
Jiang Y, Li WH, Chen YY, et al. A scoping review on risk management of peripheral vasoactive medication[J]. Chin J Nurs, 2021, 56(7):1105-1110.
DOI
URL
|
[6] |
刘佳涛, 李尊柱, 孙建华. ICU患者血管活性药物相关不良事件的影响因素及护理进展[J]. 中华现代护理杂志, 2017, 23(12):1698-1701.
|
|
Liu JT, Li ZZ, Sun JH. Contributory factors and nursing progress of vasoactive drugs-related adverse events among ICU patients[J]. Chin J Mod Nurs, 2017, 23(12):1698-1701.
|
[7] |
中国老年保健医学研究会老年内分泌与代谢病分会, 中国毒理学会临床毒理专业委员会. 老年人多重用药安全管理专家共识[J]. 中国糖尿病杂志, 2018, 26(9):705-717.
|
|
Geriatric Endocrinology and Metabolism Branch of China Gerontological Health Care and Medicine Research Society,Clinical Toxicology Committee of China Society of Toxicology. Expert consensus on risk management of polypharmacy in the elderly[J]. Chin J Diabetes, 2018, 26(9):705-717.
|
[8] |
中华护理学会静脉输液治疗专业委员会. 临床静脉导管维护操作专家共识[J]. 中华护理杂志, 2019, 54(9):1334-1342.
DOI
URL
|
|
Intravenous Infusion Nursing Committee of Chinese Nursing Association. Expert consensus on venous catheter maintenance[J]. Chin J Nurs, 2019, 54(9):1334-1342.
DOI
URL
|
[9] |
张田, 任佚, 裴艺芳, 等. 我国六城市2011—2016年医疗机构急(抢)救药品使用现状分析[J]. 中国新药杂志, 2018, 27(23):2843-2848.
|
|
Zhang T, Ren Y, Pei YF, et al. Analysis of the current situation of emergency medicine use in medical institution in six cities of China from 2011 to 2016[J]. Chin J New Drugs, 2018, 27(23):2843-2848.
|
[10] |
Loomba RS, Flores S. Use of vasoactive agents in postoperative pediatric cardiac patients:insights from a national database[J]. Congenit Heart Dis, 2019, 14(6):1176-1184.
DOI
PMID
|
[11] |
卢姣娣, 石双姣, 钟竹青. 微量泵在血管活性药物使用中的最佳证据总结[J]. 中华现代护理杂志, 2023, 29(5):581-589.
|
|
Lu JD, Shi SJ, Zhong ZQ. Summary of best evidence for micropump use in vasoactive drugs[J]. Chin J Mod Nurs, 2023, 29(5):581-589.
|
[12] |
Djogovic D, MacDonald S, Wensel A, et al. Vasopressor and inotrope use in Canadian emergency departments:evidence based consensus guidelines[J]. CJEM, 2015, 17(Suppl 1):1-16.
|